TECHNOLOGY

XSOME Biotech has combined the superior regenerative potential of lung spheroid cell exosomes (LSC-Exo) with GMP-combliant, serum- and xeno-free cell manufacturing process to develop our LSC-Exo, a proprietary exosome drug design and discovery platform.

​

By harnessing the platform technology, we have generated several pipelines of natural exosome drug candidates with proven therapeutic effects in our non-clinical studies.

​

The LSC-Exo platform has the potential to load multiple therapeutic small molecules, proteins, and antibodies to treat life-threatening lung diseases including cancer.